Sandy Spring Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $31.7K | Sell |
50
-13
| -21% | -$8.25K | ﹤0.01% | 657 |
|
|
2024
Q4 | $44.5K | Hold |
63
| – | – | ﹤0.01% | 604 |
|
|
2024
Q3 | $65.7K | Sell |
63
-3
| -5% | -$3.13K | ﹤0.01% | 536 |
|
|
2024
Q2 | $68.8K | Sell |
66
-31
| -32% | -$32.3K | ﹤0.01% | 528 |
|
|
2024
Q1 | $92.9K | Buy |
97
+33
| +52% | +$31.6K | ﹤0.01% | 476 |
|
|
2023
Q4 | $55.8K | Sell |
64
-176
| -73% | -$153K | ﹤0.01% | 544 |
|
|
2023
Q3 | $197K | Hold |
240
| – | – | 0.01% | 346 |
|
|
2023
Q2 | $172K | Buy |
240
+1
| +0.4% | +$717 | 0.01% | 366 |
|
|
2023
Q1 | $196K | Hold |
239
| – | – | 0.01% | 339 |
|
|
2022
Q4 | $172K | Buy |
239
+173
| +262% | +$125K | 0.01% | 356 |
|
|
2022
Q3 | $45K | Buy |
66
+2
| +3% | +$1.36K | ﹤0.01% | 532 |
|
|
2022
Q2 | $37K | Buy |
64
+2
| +3% | +$1.16K | ﹤0.01% | 573 |
|
|
2022
Q1 | $43K | Hold |
62
| – | – | ﹤0.01% | 572 |
|
|
2021
Q4 | $39K | Hold |
62
| – | – | ﹤0.01% | 625 |
|
|
2021
Q3 | $37K | Hold |
62
| – | – | ﹤0.01% | 628 |
|
|
2021
Q2 | $34K | Buy |
62
+50
| +417% | +$27.4K | ﹤0.01% | 660 |
|
|
2021
Q1 | $5K | Sell |
12
-4
| -25% | -$1.67K | ﹤0.01% | 877 |
|
|
2020
Q4 | $8K | Hold |
16
| – | – | ﹤0.01% | 781 |
|
|
2020
Q3 | $8K | Hold |
16
| – | – | ﹤0.01% | 705 |
|
|
2020
Q2 | $9K | Buy |
16
+4
| +33% | +$2.25K | ﹤0.01% | 714 |
|
|
2020
Q1 | $6K | Buy |
+12
| New | +$6K | ﹤0.01% | 736 |
|
|
2018
Q2 | – | Sell |
-32
| Closed | -$11K | – | 828 |
|
|
2018
Q1 | $11K | Sell |
32
-100
| -76% | -$34.4K | ﹤0.01% | 682 |
|
|
2017
Q4 | $50K | Buy |
132
+32
| +32% | +$12.1K | ﹤0.01% | 447 |
|
|
2017
Q3 | $45K | Hold |
100
| – | – | ﹤0.01% | 461 |
|
|
2017
Q2 | $49K | Hold |
100
| – | – | ﹤0.01% | 459 |
|
|
2017
Q1 | $39K | Hold |
100
| – | – | ﹤0.01% | 485 |
|
|
2016
Q4 | $37K | Hold |
100
| – | – | ﹤0.01% | 483 |
|
|
2016
Q3 | $40K | Hold |
100
| – | – | ﹤0.01% | 466 |
|
|
2016
Q2 | $35K | Hold |
100
| – | – | ﹤0.01% | 496 |
|
|
2016
Q1 | $36K | Buy |
+100
| New | +$36K | ﹤0.01% | 488 |
|